Implementing eScreening for suicide prevention in VA post-9/11 transition programs using a stepped-wedge, mixed-method, hybrid type-II implementation trial: a study protocol.

Facilitation Implementation PRISM RE-AIM Suicide Veterans eScreening

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
29 Apr 2021
Historique:
received: 15 03 2021
accepted: 25 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Post-9/11 veterans who enroll in VA health care frequently present with suicidal ideation and/or recent suicidal behavior. Most of these veterans are not screened on their day of enrollment and their risk goes undetected. Screening for suicide risk, and associated mental health factors, can lead to early detection and referral to effective treatment, thereby decreasing suicide risk. eScreening is an innovative Gold Standard Practice with evidence to support its effectiveness and implementation potential in transition and care management (TCM) programs. We will evaluate the impact of eScreening to improve the rate and speed of suicide risk screening and referral to mental health care compared to current screening methods used by transition care managers. We will also evaluate the impact of an innovative, multicomponent implementation strategy (MCIS) on the reach, adoption, implementation, and sustained use of eScreening. This is an eight-site 4-year, stepped-wedge, mixed-method, hybrid type-II implementation trial comparing eScreening to screening as usual while also evaluating the potential impact of the MCIS focusing on external facilitation and Lean/SixSigma rapid process improvement workshops in TCM. The aims will address: 1) whether using eScreening compared to oral and/or paper-based methods in TCM programs is associated with improved rates and speed of PTSD, depression, alcohol, and suicide screening & evaluation, and increased referral to mental health treatment; 2) whether and to what degree our MCIS is feasible, acceptable, and has the potential to impact adoption, implementation, and maintenance of eScreening; and 3) how contextual factors influence the implementation of eScreening between high- and low-eScreening adopting sites. We will use a mixed methods approach guided by the RE-AIM outcomes of the Practical Robust Implementation and Sustainability Model (PRISM). Data to address Aim 1 will be collected via medical record query while data for Aims 2 and 3 will be collected from TCM staff questionnaires and qualitative interviews. The results of this study will help identify best practices for screening in suicide prevention for Post-9/11 veterans enrolling in VA health care and will provide information on how best to implement technology-based screening into real-world clinical care programs. ClinicalTrials.gov : NCT04506164; date registered: August 20, 2020; retrospectively registered.

Sections du résumé

BACKGROUND BACKGROUND
Post-9/11 veterans who enroll in VA health care frequently present with suicidal ideation and/or recent suicidal behavior. Most of these veterans are not screened on their day of enrollment and their risk goes undetected. Screening for suicide risk, and associated mental health factors, can lead to early detection and referral to effective treatment, thereby decreasing suicide risk. eScreening is an innovative Gold Standard Practice with evidence to support its effectiveness and implementation potential in transition and care management (TCM) programs. We will evaluate the impact of eScreening to improve the rate and speed of suicide risk screening and referral to mental health care compared to current screening methods used by transition care managers. We will also evaluate the impact of an innovative, multicomponent implementation strategy (MCIS) on the reach, adoption, implementation, and sustained use of eScreening.
METHODS METHODS
This is an eight-site 4-year, stepped-wedge, mixed-method, hybrid type-II implementation trial comparing eScreening to screening as usual while also evaluating the potential impact of the MCIS focusing on external facilitation and Lean/SixSigma rapid process improvement workshops in TCM. The aims will address: 1) whether using eScreening compared to oral and/or paper-based methods in TCM programs is associated with improved rates and speed of PTSD, depression, alcohol, and suicide screening & evaluation, and increased referral to mental health treatment; 2) whether and to what degree our MCIS is feasible, acceptable, and has the potential to impact adoption, implementation, and maintenance of eScreening; and 3) how contextual factors influence the implementation of eScreening between high- and low-eScreening adopting sites. We will use a mixed methods approach guided by the RE-AIM outcomes of the Practical Robust Implementation and Sustainability Model (PRISM). Data to address Aim 1 will be collected via medical record query while data for Aims 2 and 3 will be collected from TCM staff questionnaires and qualitative interviews.
DISCUSSION CONCLUSIONS
The results of this study will help identify best practices for screening in suicide prevention for Post-9/11 veterans enrolling in VA health care and will provide information on how best to implement technology-based screening into real-world clinical care programs.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov : NCT04506164; date registered: August 20, 2020; retrospectively registered.

Identifiants

pubmed: 33926577
doi: 10.1186/s43058-021-00142-9
pii: 10.1186/s43058-021-00142-9
pmc: PMC8082763
doi:

Banques de données

ClinicalTrials.gov
['NCT04506164']

Types de publication

Journal Article

Langues

eng

Pagination

46

Subventions

Organisme : HSRD VA
ID : I01 HX003079
Pays : United States
Organisme : Health Services Research and Development
ID : 1I01HX003079-01A1

Références

JAMA. 2017 Jan 17;317(3):255-256
pubmed: 28114562
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
J Wound Ostomy Continence Nurs. 2011 Mar-Apr;38(2):155-9
pubmed: 21326117
J Trauma Stress. 2009 Aug;22(4):303-6
pubmed: 19626682
J Affect Disord. 2010 Jun;123(1-3):102-7
pubmed: 19819559
J Nerv Ment Dis. 1994 Nov;182(11):604-10
pubmed: 7964667
Am J Public Health. 2012 Mar;102 Suppl 1:S17-9
pubmed: 22390592
Workplace Health Saf. 2017 Sep;65(9):430-444
pubmed: 28849739
Pediatrics. 2010 May;125(5):945-52
pubmed: 20385642
Health Serv Res. 2013 Dec;48(6 Pt 2):2125-33
pubmed: 24279834
Med Care. 2015 Feb;53(2):184-90
pubmed: 25464164
J Gen Intern Med. 2014 Dec;29 Suppl 4:904-12
pubmed: 25355087
JAMA Psychiatry. 2014 May;71(5):493-503
pubmed: 24590048
BMC Health Serv Res. 2017 Apr 20;17(1):294
pubmed: 28424052
J Behav Health Serv Res. 2015 Oct;42(4):504-18
pubmed: 24464179
BMC Health Serv Res. 2017 Aug 3;17(1):523
pubmed: 28774301
Drug Alcohol Depend. 2011 Jul 1;116(1-3):93-101
pubmed: 21277712
Jt Comm J Qual Patient Saf. 2008 Apr;34(4):228-43
pubmed: 18468362
Ann Epidemiol. 2006 Apr;16(4):248-56
pubmed: 16099672
Med Care. 2019 Nov;57(11):920
pubmed: 31609848
JAMA Psychiatry. 2014 May;71(5):514-22
pubmed: 24590178
Implement Sci. 2016 Oct 26;11(1):146
pubmed: 27782832
BMJ Qual Saf. 2014 Apr;23(4):290-8
pubmed: 24025320
Heredity (Edinb). 2005 Sep;95(3):221-7
pubmed: 16077740
J Gen Intern Med. 2019 May;34(Suppl 1):58-66
pubmed: 31098972
JAMA. 2008 Aug 13;300(6):652-3
pubmed: 18698062
Suicidologi. 2018;23(1):22-30
pubmed: 29970972
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78
pubmed: 11816692
Value Health. 2009 Jun;12(4):419-29
pubmed: 19900250
Psychiatr Serv. 2015 Sep;66(9):959-65
pubmed: 25930036
J Nurs Care Qual. 2019 Jul/Sep;34(3):210-216
pubmed: 30480614
Front Public Health. 2020 Jul 03;8:245
pubmed: 32719761
Implement Sci. 2013 Oct 02;8:117
pubmed: 24088228
Implement Sci. 2016 Apr 30;11:58
pubmed: 27130272
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Implement Sci. 2018 Mar 29;13(1):53
pubmed: 29598824
Med Care. 2016 Apr;54(4):400-5
pubmed: 26908085
JAMA. 2013 Aug 7;310(5):496-506
pubmed: 23925620
Psychiatr Serv. 2012 Dec;63(12):1206-12
pubmed: 23070131
Jt Comm J Qual Patient Saf. 2015 Jan;41(1):26-2
pubmed: 25976721
Psychol Serv. 2017 Feb;14(1):23-33
pubmed: 28134554
Implement Sci Commun. 2021 Apr 7;2(1):37
pubmed: 33827705
Transl Behav Med. 2019 Nov 25;9(6):1002-1011
pubmed: 31170296
Ann Fam Med. 2012 Jan-Feb;10(1):63-74
pubmed: 22230833
Implement Sci. 2006 Oct 18;1:23
pubmed: 17049080
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Implement Sci. 2014 Dec 28;9:163
pubmed: 25544027
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
JAMA. 2012 Aug 15;308(7):671-2
pubmed: 22893160
J Psychiatr Res. 2015 Sep;68:120-4
pubmed: 26228410
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Healthc Qual. 2006 Mar-Apr;28(2):4-11
pubmed: 16749293
J Gen Intern Med. 2006 Mar;21 Suppl 3:S58-64
pubmed: 16637948
BMC Med Res Methodol. 2018 Nov 27;18(1):153
pubmed: 30482159
Clin Infect Dis. 2010 Apr 15;50(8):1165-73
pubmed: 20210646
Adm Policy Ment Health. 2011 Jan;38(1):44-53
pubmed: 20967495
Front Public Health. 2018 Apr 09;6:102
pubmed: 29686983
J Gen Intern Med. 2020 Apr;35(4):1001-1010
pubmed: 31792866

Auteurs

James O E Pittman (JOE)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA. james.pittman@va.gov.
VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA, USA. james.pittman@va.gov.
Department of Psychiatry, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, USA. james.pittman@va.gov.

Laurie Lindamer (L)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA.
VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA, USA.
Department of Psychiatry, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, USA.

Niloofar Afari (N)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA.
VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA, USA.
Department of Psychiatry, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, USA.

Colin Depp (C)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA.
VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA, USA.
Department of Psychiatry, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, USA.

Miguel Villodas (M)

San Diego State University, 5500 Campanile Dr, San Diego, CA, USA.

Alison Hamilton (A)

VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd, Los Angeles, CA, USA.

Bo Kim (B)

HSR&D Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, 150 South Huntington Avenue, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA.

Maria K Mor (MK)

VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
VA Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.

Erin Almklov (E)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA.
VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA, USA.

John Gault (J)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA.
VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA, USA.

Borsika Rabin (B)

VA Center of Excellence for Stress and Mental Health, 3350 La Jolla Village Dr, San Diego, CA, USA.
UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, USA.
UC San Diego Dissemination and Implementation Science Center, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, USA.

Classifications MeSH